The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 522.00
Bid: 521.00
Ask: 522.00
Change: 1.50 (0.29%)
Spread: 1.00 (0.192%)
Open: 522.00
High: 525.00
Low: 521.00
Prev. Close: 520.50
BAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re: article in The Sunday Times

30 Jul 2018 07:00

RNS Number : 0860W
Babcock International Group PLC
30 July 2018
 

30 July 2018

 

Babcock International Group PLC (Babcock or the Group)

 

Babcock, the engineering services company, provides the following clarification regarding a misleading article published by the Sunday Times on 29 July 2018.

 

As regards trading, Babcock's Trading Statement of 19 July 2018 reiterated its underlying earnings guidance for financial year 2018/19, despite forecasting slightly lower underlying revenue growth than had initially been expected. The statement also reported that the bid pipeline had increased by £1 billion to c£14 billion.

 

As regards contracts, the article confuses Babcock's existing DSG contract, which runs until 2025, with an entirely separate tender for Protected Mobility Strategic Support Supplier (PM SSS) which initially came to market in 2015 but which did not proceed to competition following a decision to halt the procurement process in December 2016. 

 

DSG is a long term service provision and transformation contract for a wide range of equipment, maintenance, spares supply and platform overhaul with the UK Ministry of Defence (MOD). As part of this long term partnership contract Babcock is able to make further proposals for transformation and performance improvement to the customer. One such recent proposal related to putting a number of different vehicle types onto an availability service - this was designated Strategic Support Supplier (SSS). Following discussion, the MOD has decided instead to focus on deepening the transformation and the relationship with Babcock on the core contract, which continues to offer the Army significant flexibility. The existing contract offers Babcock significant exclusivity over the various service categories.

 

There has been no change to the Company's expectations for underlying revenue and underlying earnings as detailed in its recent Trading Statement, and no change to the bid pipeline. The impact of slower than anticipated spares procurement activity relating to DSG was included in the guidance issued at the time. We look forward to continuing to work closely with the Army and MOD to deliver the transformation in vehicle availability and performance which is at the core of our long term Babcock DSG transformation contract.

 

 

Enquiries

 

Babcock International Group PLC

020 7355 5300

Archie BethelFranco Martinelli

Kate Hill

FTI Consulting

020 3727 1340

Andrew Lorenz

Nick Hasell

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
SPCRLMMTMBITTIP
Date   Source Headline
1st Mar 20247:00 amRNSContract awarded to refit UK nuclear submarine
21st Feb 20245:58 pmRNSDirector/PDMR Shareholding
15th Feb 20247:05 amRNSDirector announcement
14th Feb 20245:36 pmRNSDirector/PDMR Shareholding
14th Feb 20249:00 amRNSDirector appointment
9th Feb 20244:26 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNSCapital Markets Day
6th Feb 20244:58 pmRNSDirector/PDMR Shareholding
5th Feb 202411:29 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSAmended Capital Markets Day start time
12th Jan 20247:00 amRNSNotice of Capital Markets Day
15th Dec 20234:51 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
10th Nov 202312:00 pmRNSBabcock signs £750 million infrastructure contract
7th Nov 20233:24 pmRNSHolding(s) in Company
30th Oct 20231:55 pmRNSHolding(s) in Company
28th Sep 20236:12 pmRNSResult of AGM
28th Sep 20237:00 amRNSAGM trading update
26th Sep 20235:57 pmRNSHolding(s) in Company
26th Sep 20235:56 pmRNSHolding(s) in Company
22nd Aug 20238:54 amRNSDirector/PDMR Shareholding
17th Aug 20232:52 pmRNSNotice of AGM
16th Aug 20235:16 pmRNSDirector/PDMR Shareholding
9th Aug 202310:00 amRNSDirector/PDMR Shareholding
4th Aug 20233:24 pmRNSDirector/PDMR Shareholding
3rd Aug 20233:34 pmRNSDirector/PDMR Shareholding
3rd Aug 202310:19 amRNSDirector/PDMR Shareholding
2nd Aug 20233:25 pmRNSDirector/PDMR Shareholding
2nd Aug 202310:22 amRNSDirector/PDMR Shareholding
31st Jul 20239:22 amRNSAnnual Financial Report
20th Jul 20237:16 amRNSFull year results for the year ended 31 March 2023
11th Jul 20237:00 amRNSDate of publication of FY23 preliminary statement
24th May 20238:54 amRNSDirectorate Change
20th Apr 20237:00 amRNSFY23 post close update and Type 31 contract update
1st Mar 20237:00 amRNSDisposal programme successfully concluded
15th Feb 20239:09 amRNSBabcock awarded contract to operate Skynet
2nd Feb 20238:13 amRNSDirectorate Change
20th Dec 202212:54 pmRNSStandard & Poor credit rating upgrade
9th Dec 20229:29 amRNSHolding(s) in Company
8th Dec 20229:06 amRNSHolding(s) in Company
22nd Nov 20227:00 amRNSHalf-year Report
9th Nov 20224:48 pmRNSHolding(s) in Company
3rd Nov 202212:13 pmRNSRestatement of pass-through revenue for HY22
3rd Nov 202211:08 amRNSRestatement of H1 2022 Results
21st Oct 20228:05 amRNSContract Win
18th Oct 20229:00 amRNSDirector appointment
13th Oct 202210:41 amRNSHolding(s) in Company
26th Sep 20224:00 pmRNSResult of AGM
26th Sep 20227:00 amRNSAGM Trading Update
12th Sep 20221:25 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.